{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:26:10Z","timestamp":1794655570512,"version":"4.9.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jmgm.2026.109321","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:42:51Z","timestamp":1770450171000},"page":"109321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["In silico assessment of benzyl C-analogues of dapagliflozin as potential SGLT2 inhibitors for type 2 diabetes"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0843-222X","authenticated-orcid":false,"given":"Mwashi F.","family":"Misungwi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2941-8668","authenticated-orcid":false,"given":"Geradius","family":"Deogratias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1009-3757","authenticated-orcid":false,"given":"Lucas","family":"Kwiyukwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0811-5817","authenticated-orcid":false,"given":"Sixberth","family":"Mlowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2748-0783","authenticated-orcid":false,"given":"Andrew S.","family":"Paluch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1693-9173","authenticated-orcid":false,"given":"Lucas","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2026.109321_b1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000497580","article-title":"Diabetes mellitus and its treatment","volume":"13","author":"Bastaki","year":"2005","journal-title":"Int. J. Diabetes Metab."},{"key":"10.1016\/j.jmgm.2026.109321_b2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.47672\/ejb.409","article-title":"A modern overview on diabetes mellitus: a chronic endocrine disorder","volume":"5","author":"Mukhtar","year":"2020","journal-title":"Eur. J. Biol."},{"key":"10.1016\/j.jmgm.2026.109321_b3","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2026.109321_b4","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.2004","article-title":"Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused","volume":"7","author":"Hossain","year":"2024","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109321_b5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2047487319881021","article-title":"The global epidemics of diabetes in the 21st century: Current situation and perspectives","volume":"26","author":"Standl","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.jmgm.2026.109321_b6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes\u2014global burden of disease and forecasted trends","volume":"10","author":"Abdul Basith Khan","year":"2020","journal-title":"J. Epidemiol. Glob. Health"},{"key":"10.1016\/j.jmgm.2026.109321_b7","series-title":"Obesity and type 2 diabetes: A joint approach to halt the rise","year":"2022"},{"key":"10.1016\/j.jmgm.2026.109321_b8","first-page":"147","article-title":"International diabetes federation","volume":"102","author":"Webber","year":"2021","journal-title":"Int. J. Diabetes"},{"key":"10.1016\/j.jmgm.2026.109321_b9","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820980225","article-title":"Should metformin remain the first-line therapy for treatment of type 2 diabetes?","volume":"12","author":"Baker","year":"2021","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.jmgm.2026.109321_b10","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s40520-020-01736-4","article-title":"Sulfonylureas use and fractures risk in elderly patients with type 2 diabetes mellitus: a meta-analysis study","volume":"33","author":"Tao","year":"2021","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.jmgm.2026.109321_b11","article-title":"Metformin: A review of its therapeutic efficacy and adverse effects","volume":"17","author":"Shurrab","year":"2020","journal-title":"Obes. Med."},{"key":"10.1016\/j.jmgm.2026.109321_b12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1568026620666191224141617","article-title":"Mechanisms and characteristics of sulfonylureas and glinides","volume":"20","author":"Lv","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109321_b13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MED.0000000000000311","article-title":"An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus","volume":"24","author":"Hsia","year":"2017","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.jmgm.2026.109321_b14","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00125-018-4654-7","article-title":"Development of SGLT1 and SGLT2 inhibitors","volume":"61","author":"Rieg","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jmgm.2026.109321_b15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/diseases8020014","article-title":"SGLT2 inhibitors: the star in the treatment of type 2 diabetes?","volume":"8","author":"Saisho","year":"2020","journal-title":"Diseases"},{"key":"10.1016\/j.jmgm.2026.109321_b16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/DMSO.S233538","article-title":"Extraglycemic effects of SGLT2 inhibitors: a review of the evidence","author":"Bonora","year":"2020","journal-title":"Diabetes, Metab. Syndr. Obes."},{"key":"10.1016\/j.jmgm.2026.109321_b17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","article-title":"Effects of SGLT2 inhibitors on kidney and cardiovascular function","volume":"83","author":"Vallon","year":"2021","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jmgm.2026.109321_b18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1515\/jom-2020-0153","article-title":"SGLT2 inhibitors: a narrative review of efficacy and safety","volume":"121","author":"Nelinson","year":"2021","journal-title":"J. Osteopat. Med."},{"key":"10.1016\/j.jmgm.2026.109321_b19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.hfc.2022.03.009","article-title":"SGLT2 inhibitors in type 2 diabetes mellitus","volume":"18","author":"Ferrannini","year":"2022","journal-title":"Hear. Fail. Clin."},{"key":"10.1016\/j.jmgm.2026.109321_b20","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.cgh.2020.05.021","article-title":"SGLT2 inhibitors in liver patients","volume":"18","author":"Hsiang","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jmgm.2026.109321_b21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/metabo11020087","article-title":"The effects of SGLT2 inhibitors on lipid metabolism","volume":"11","author":"Szekeres","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.jmgm.2026.109321_b22","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/ejoc.202000025","article-title":"Synthesis of benzyl C-analogues of dapagliflozin as potential SGLT2 inhibitors","author":"Mukkamala","year":"2020","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.jmgm.2026.109321_b23","series-title":"Bioinformatics","first-page":"207","article-title":"Computational approaches in drug designing","author":"Tiwari","year":"2022"},{"key":"10.1016\/j.jmgm.2026.109321_b24","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109321_b25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2174\/1570180819666220922103109","article-title":"Molecular docking: Principles, advances, and its applications in drug discovery","volume":"21","author":"Muhammed","year":"2024","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.jmgm.2026.109321_b26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-3-030-36260-7_10","article-title":"Molecular dynamics simulations in drug discovery and drug delivery","author":"Saurabh","year":"2020","journal-title":"Integr. Nanomed. New Ther."},{"key":"10.1016\/j.jmgm.2026.109321_b27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field. I. basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2026.109321_b28","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.3390\/molecules26195957","article-title":"Multi-targeted molecular docking, pharmacokinetics, and drug-likeness evaluation of okra-derived ligand abscisic acid targeting signaling proteins involved in the development of diabetes","volume":"26","author":"Ashraf","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2026.109321_b29","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109321_b30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today: Technol."},{"key":"10.1016\/j.jmgm.2026.109321_b31","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109321_b32","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2026.109321_b33","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2026.109321_b34","doi-asserted-by":"crossref","DOI":"10.2196\/14232","article-title":"Molecular docking using chimera and autodock vina software for nonbioinformaticians","volume":"1","author":"Butt","year":"2020","journal-title":"JMIR Bioinform. Biotechnol."},{"key":"10.1016\/j.jmgm.2026.109321_b35","first-page":"1","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.jmgm.2026.109321_b36","first-page":"1","article-title":"Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease","author":"Shivanika","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109321_b37","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4213","article-title":"RCSB protein data bank: Tools for visualizing and understanding biological macromolecules in 3d","volume":"31","author":"Burley","year":"2022","journal-title":"Prot. Sci."},{"key":"10.1016\/j.jmgm.2026.109321_b38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-1-4939-6952-4_20","article-title":"Autodock and AutoDockTools for protein-ligand docking: beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a case study","author":"El-Hachem","year":"2017","journal-title":"Neuroproteom.: Methods Protoc."},{"key":"10.1016\/j.jmgm.2026.109321_b39","doi-asserted-by":"crossref","first-page":"W537","DOI":"10.1093\/nar\/gks375","article-title":"H++ 3.0: automating p k prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations","volume":"40","author":"Anandakrishnan","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2026.109321_b40","first-page":"27","article-title":"Application of molecular docking and drug-likeness prediction for the discovery of new antidiabetic agents","volume":"36","author":"Merzoug","year":"2024","journal-title":"Pharmakeftiki"},{"key":"10.1016\/j.jmgm.2026.109321_b41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: Structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jmgm.2026.109321_b42","series-title":"Ccp4 newsletter on protein crystallography","author":"Briggs","year":"2002"},{"key":"10.1016\/j.jmgm.2026.109321_b43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/nar\/gkaa235","article-title":"Proteins plus: interactive analysis of protein\u2013ligand binding interfaces","volume":"48","author":"Sch\u00f6ning-Stierand","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2026.109321_b44","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2026.109321_b45","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2026.109321_b46","doi-asserted-by":"crossref","first-page":"W331","DOI":"10.1093\/nar\/gkx312","article-title":"LigParGen web server: an automatic OPLS-AA parameter generator for organic ligands","volume":"45","author":"Dodda","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2026.109321_b47","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.1063\/1.1683075","article-title":"Development of an improved four-site water model for biomolecular simulations: TIP4P-Ew","volume":"120","author":"Horn","year":"2004","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2026.109321_b48","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.33011\/livecoms.1.1.5068","article-title":"From proteins to perturbed Hamiltonians: a suite of tutorials for the GROMACS-2018 molecular simulation package [article v1. 0]","volume":"1","author":"Lemkul","year":"2018","journal-title":"Living J. Comput. Mol. Sci."},{"key":"10.1016\/j.jmgm.2026.109321_b49","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2026.109321_b50","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: A new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.jmgm.2026.109321_b51","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2026.109321_b52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s43586-022-00184-w","article-title":"Principal component analysis","volume":"2","author":"Greenacre","year":"2022","journal-title":"Nat. Rev. Methods Prim."},{"key":"10.1016\/j.jmgm.2026.109321_b53","doi-asserted-by":"crossref","DOI":"10.1002\/qua.26555","article-title":"Deterministic quantum mechanics: The role of the maxwell\u2013boltzmann distribution","volume":"121","author":"B\u00fcchel","year":"2021","journal-title":"Int. J. Quantum Chem."},{"key":"10.1016\/j.jmgm.2026.109321_b54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13321-023-00678-z","article-title":"Critical assessment of synthetic accessibility scores in computer-assisted synthesis planning","volume":"15","author":"Skoraczy\u0144ski","year":"2023","journal-title":"J. Cheminform."},{"key":"10.1016\/j.jmgm.2026.109321_b55","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/acs.jcim.6b00465","article-title":"Phantom PAINS: Problems with the utility of alerts for pan- assay interference compound S","volume":"57","author":"Capuzzi","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2026.109321_b56","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/biomedicines10092055","article-title":"Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics","volume":"10","author":"Bhalani","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jmgm.2026.109321_b57","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.3390\/molecules28227532","article-title":"Study models of drug\u2013drug interactions involving p-glycoprotein: the potential benefit of p-glycoprotein modulation at the kidney and intestinal levels","volume":"28","author":"Veiga-Matos","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2026.109321_b58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/antiox13020215","article-title":"Regulation of P-glycoprotein during oxidative stress","volume":"13","author":"Shchulkin","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.jmgm.2026.109321_b59","first-page":"1","article-title":"CYP3A4 drug metabolism considerations in pediatric pharmacotherapy","author":"Vander Schaaf","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jmgm.2026.109321_b60","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/biomedicines12071467","article-title":"Decoding the role of CYP450 enzymes in metabolism and disease: A comprehensive review","volume":"12","author":"Abdelmonem","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jmgm.2026.109321_b61","first-page":"316","article-title":"What the drugs does to the body: pharmacodynamics","volume":"10","author":"Bereda","year":"2022","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109321_b62","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1208\/s12248-021-00591-z","article-title":"There is only one valid definition of clearance: critical examination of clearance concepts reveals the potential for errors in clinical drug dosing decisions","volume":"23","author":"Benet","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.jmgm.2026.109321_b63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40959-025-00343-4","article-title":"The effects of sodium-glucose cotransporter-2 inhibitors in chemotherapy-induced cardiotoxicity and mortality in patients with cancer: a systematic review and meta-analysis","volume":"11","author":"Reshadmanesh","year":"2025","journal-title":"Cardio-Oncology"},{"key":"10.1016\/j.jmgm.2026.109321_b64","doi-asserted-by":"crossref","first-page":"716","DOI":"10.56499\/jppres24.2104_13.3.716","article-title":"In silico discovery of potential sodium glucose cotransporter-2 (SGLT-2) inhibitors from Smallanthus sonchifolius (Poepp.) H. Rob. via molecular docking and molecular dynamics simulation approach","volume":"13","author":"Prasetiyo","year":"2025","journal-title":"J. Pharm. Pharmacogn. Res."},{"key":"10.1016\/j.jmgm.2026.109321_b65","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1080\/07391102.2022.2130983","article-title":"In silico discovery of potential sodium\u2013glucose cotransporter-2 inhibitors from natural products for treatment of heart failure via molecular docking and molecular dynamics simulation approach","volume":"41","author":"Kong","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109321_b66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s44371-025-00128-9","article-title":"Molecular docking and pharmacokinetic evaluations of curcumin-based scaffolds as MDM2-p53 inhibitors","volume":"2","author":"Kurmi","year":"2025","journal-title":"Discov. Chem."},{"key":"10.1016\/j.jmgm.2026.109321_b67","doi-asserted-by":"crossref","first-page":"138","DOI":"10.22159\/ijap.2022v14i4.44390","article-title":"Molecular docking study of the major compounds from garcinia atroviridis on human sglt-2 protein transport using structure-based drug design method","volume":"14","author":"Kuswandi","year":"2022","journal-title":"Int. J. App. Pharm."},{"key":"10.1016\/j.jmgm.2026.109321_b68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41594-023-01134-0","article-title":"Transport and inhibition mechanism of the human SGLT2\u2013MAP17 glucose transporter","volume":"31","author":"Hiraizumi","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jmgm.2026.109321_b69","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.xphs.2021.01.002","article-title":"Molecular dynamics simulation to uncover the mechanisms of protein instability during freezing","volume":"110","author":"Duran","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jmgm.2026.109321_b70","doi-asserted-by":"crossref","DOI":"10.1177\/11779322231223851","article-title":"Neomangiferin, a naturally occurring mangiferin congener, inhibits sodium-glucose co-transporter-2: an in silico approach","volume":"18","author":"Olusola","year":"2024","journal-title":"Bioinform. Biol. Insights"},{"key":"10.1016\/j.jmgm.2026.109321_b71","doi-asserted-by":"crossref","DOI":"10.1142\/S021972002050050X","article-title":"Scaling laws of graphs of 3d protein structures","volume":"19","author":"Praz\u0148ikar","year":"2021","journal-title":"J. Bioinform. Comput. Biol."},{"key":"10.1016\/j.jmgm.2026.109321_b72","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/978-1-0716-0524-0_21","article-title":"Computing, analyzing, and comparing the radius of gyration and hydrodynamic radius in conformational ensembles of intrinsically disordered proteins","author":"Ahmed","year":"2020","journal-title":"Intrinsically Disord. Proteins: Methods Protoc."},{"key":"10.1016\/j.jmgm.2026.109321_b73","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1038\/s41467-025-62421-6","article-title":"Mechanism of substrate recognition and release of human sglt2","volume":"16","author":"Cui","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2026.109321_b74","series-title":"Ohio Supercomputer Center","year":"1987"}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:15:49Z","timestamp":1772525749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326326000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":74,"alternative-id":["S1093326326000471"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109321","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico assessment of benzyl C-analogues of dapagliflozin as potential SGLT2 inhibitors for type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109321"}}